Taipei LedgerData Analysis on Taiwan's Companies and Economy

Company profile · Biotech & medical

Foresee Pharmaceuticals

逸達生物科技股份有限公司 · 6576

What it does

Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.

Foresee Pharmaceuticals is a biopharmaceutical company that develops new drugs.[1]

The company focuses its research and development on a Stabilized Injectable Formulation long-acting injectable technology and preclinical and clinical first-in-class New Chemical Entity programs targeting rare and common severe diseases.[2]

Its product portfolio includes CAMCEVI, a long-acting injectable for the treatment of advanced prostate cancer, as well as programs for central precocious puberty and neurology and psychiatry drugs.[2]

The company also develops oral small molecule drugs such as aderamastat for inflammatory and fibrotic diseases and mirivadelgat for pulmonary hypertension associated with interstitial lung diseases.[2]

Foresee Pharmaceuticals is based in Taiwan and the United States.[2]

Monthly revenue

Latest monthRevenueYear on yearMonth on month
2026-10NT$125m+397.5%+1895.4%
2024-11: NT$0.01bn2024-12: NT$0.02bn2025-01: NT$0.01bn2025-02: NT$0.07bn2025-03: NT$0.03bn2025-04: NT$0.06bn2025-05: NT$0.01bn2025-06: NT$0.04bn2025-07: NT$0.01bn2025-08: NT$0.14bn2025-09: NT$0.01bn2025-10: NT$0.03bn2025-11: NT$0.01bn2025-12: NT$0.01bn2026-01: NT$0.01bn2026-02: NT$0.03bn2026-03: NT$0.04bn2026-04: NT$0.05bn2026-05: NT$0.12bn2026-06: NT$0.01bn2026-07: NT$0.03bn2026-08: NT$0.03bn2026-09: NT$0.01bn2026-10: NT$0.13bn

2024-11 to 2026-10, monthly revenue.

Foreign investors

Last 20 trading daysNet
2026-10-12 to 2026-11-10−NT$27m
2026-10-12: −NT$20m2026-10-13: −NT$3m2026-10-14: −NT$2m2026-10-15: +NT$0m2026-10-16: +NT$1m2026-10-19: −NT$0m2026-10-20: −NT$0m2026-10-21: +NT$2m2026-10-22: −NT$0m2026-10-27: −NT$0m2026-10-28: −NT$0m2026-10-29: +NT$1m2026-10-30: −NT$0m2026-11-02: −NT$0m2026-11-03: −NT$2m2026-11-04: +NT$0m2026-11-05: +NT$1m2026-11-06: +NT$2m2026-11-09: −NT$3m2026-11-10: −NT$3m

Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.

Facts

Full English nameForesee Pharmaceuticals Co., Ltd.
Chinese name逸達生物科技股份有限公司
Stock code6576 (TPEx)
IndustryBiotech & medical
Founded08 Feb 2013
Listed29 Jun 2018
Paid-in capitalNT$1.6bn
Chairman簡銘達
President簡銘達
Headquarters9F-2., No.19-3, Sanchong Rd., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)
Websitehttps://www.foreseepharma.com
Official business description新藥研發

Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.

Sources

  1. MOPS 公司基本資料 逸達生物科技股份有限公司 · mops · retrieved 04 Nov 2026
  2. Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
The Week in Taiwan Companies · free, every Friday
Using it at work? Join the team-plan waiting list

Generated 2026-11-11 00:39.